Literature DB >> 28122242

PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival.

Yunjong Lee1, Daniel A Stevens2, Sung-Ung Kang3, Haisong Jiang3, Yun-Il Lee4, Han Seok Ko3, Leslie A Scarffe2, George E Umanah4, Hojin Kang5, Sangwoo Ham5, Tae-In Kam4, Kathleen Allen3, Saurav Brahmachari6, Jungwoo Wren Kim7, Stewart Neifert3, Seung Pil Yun4, Fabienne C Fiesel8, Wolfdieter Springer8, Valina L Dawson9, Joo-Ho Shin10, Ted M Dawson11.   

Abstract

Mutations in PTEN-induced putative kinase 1 (PINK1) and parkin cause autosomal-recessive Parkinson's disease through a common pathway involving mitochondrial quality control. Parkin inactivation leads to accumulation of the parkin interacting substrate (PARIS, ZNF746) that plays an important role in dopamine cell loss through repression of proliferator-activated receptor gamma coactivator-1-alpha (PGC-1α) promoter activity. Here, we show that PARIS links PINK1 and parkin in a common pathway that regulates dopaminergic neuron survival. PINK1 interacts with and phosphorylates serines 322 and 613 of PARIS to control its ubiquitination and clearance by parkin. PINK1 phosphorylation of PARIS alleviates PARIS toxicity, as well as repression of PGC-1α promoter activity. Conditional knockdown of PINK1 in adult mouse brains leads to a progressive loss of dopaminergic neurons in the substantia nigra that is dependent on PARIS. Altogether, these results uncover a function of PINK1 to direct parkin-PARIS-regulated PGC-1α expression and dopaminergic neuronal survival.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PARIS; PGC-1α; PINK1; Parkinson’s disease; ZNF746; parkin; ubiquitin

Mesh:

Substances:

Year:  2017        PMID: 28122242      PMCID: PMC5312976          DOI: 10.1016/j.celrep.2016.12.090

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  76 in total

1.  Site-specific Interaction Mapping of Phosphorylated Ubiquitin to Uncover Parkin Activation.

Authors:  Koji Yamano; Bruno B Queliconi; Fumika Koyano; Yasushi Saeki; Takatsugu Hirokawa; Keiji Tanaka; Noriyuki Matsuda
Journal:  J Biol Chem       Date:  2015-08-10       Impact factor: 5.157

Review 2.  Parkin and mitochondrial quality control: toward assembling the puzzle.

Authors:  Konstanze F Winklhofer
Journal:  Trends Cell Biol       Date:  2014-01-30       Impact factor: 20.808

3.  Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutations.

Authors:  Helen I Woodroof; Joe H Pogson; Mike Begley; Lewis C Cantley; Maria Deak; David G Campbell; Daan M F van Aalten; Alexander J Whitworth; Dario R Alessi; Miratul M K Muqit
Journal:  Open Biol       Date:  2011-11       Impact factor: 6.411

4.  Regulation of PINK1 by NR2B-containing NMDA receptors in ischemic neuronal injury.

Authors:  Yuexin Shan; Baosong Liu; Lijun Li; Ning Chang; Lei Li; Hanbin Wang; Dianshi Wang; Hua Feng; Carol Cheung; Mingxia Liao; Tianyuan Cui; Shuzo Sugita; Qi Wan
Journal:  J Neurochem       Date:  2009-09-22       Impact factor: 5.372

Review 5.  Mitochondrial quality control turns out to be the principal suspect in parkin and PINK1-related autosomal recessive Parkinson's disease.

Authors:  Olga Corti; Alexis Brice
Journal:  Curr Opin Neurobiol       Date:  2012-11-30       Impact factor: 6.627

6.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.

Authors:  Sven Geisler; Kira M Holmström; Diana Skujat; Fabienne C Fiesel; Oliver C Rothfuss; Philipp J Kahle; Wolfdieter Springer
Journal:  Nat Cell Biol       Date:  2010-01-24       Impact factor: 28.824

7.  Structural determinants of PINK1 topology and dual subcellular distribution.

Authors:  William Lin; Un Jung Kang
Journal:  BMC Cell Biol       Date:  2010-11-22       Impact factor: 4.241

8.  Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease.

Authors:  Joanne Clark; Sonika Reddy; Kangni Zheng; Rebecca A Betensky; David K Simon
Journal:  BMC Med Genet       Date:  2011-05-19       Impact factor: 2.103

9.  PGC-1α Promoter Methylation in Parkinson's Disease.

Authors:  Xiaomin Su; Yaping Chu; Jeffrey H Kordower; Bin Li; Hong Cao; Liang Huang; Maki Nishida; Lei Song; Difei Wang; Howard J Federoff
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

10.  PGC-1α modulates denervation-induced mitophagy in skeletal muscle.

Authors:  Anna Vainshtein; Eric Ma Desjardins; Andrea Armani; Marco Sandri; David A Hood
Journal:  Skelet Muscle       Date:  2015-03-18       Impact factor: 4.912

View more
  66 in total

1.  Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.

Authors:  Saurav Brahmachari; Saebom Lee; Sangjune Kim; Changqing Yuan; Senthilkumar S Karuppagounder; Preston Ge; Rosa Shi; Esther J Kim; Alex Liu; Donghoon Kim; Stephan Quintin; Haisong Jiang; Manoj Kumar; Seung Pil Yun; Tae-In Kam; Xiaobo Mao; Yunjong Lee; Deborah A Swing; Lino Tessarollo; Han Seok Ko; Valina L Dawson; Ted M Dawson
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

Review 2.  Shedding light on mitophagy in neurons: what is the evidence for PINK1/Parkin mitophagy in vivo?

Authors:  Nadia Cummins; Jürgen Götz
Journal:  Cell Mol Life Sci       Date:  2017-10-30       Impact factor: 9.261

3.  Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.

Authors:  Nicolas Giguère; Consiglia Pacelli; Caroline Saumure; Marie-Josée Bourque; Diana Matheoud; Daniel Levesque; Ruth S Slack; David S Park; Louis-Éric Trudeau
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

Review 4.  Multiple pathways for mitophagy: A neurodegenerative conundrum for Parkinson's disease.

Authors:  Charleen T Chu
Journal:  Neurosci Lett       Date:  2018-04-04       Impact factor: 3.046

5.  PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

Authors:  Cristina Guardia-Laguarta; Yuhui Liu; Knut H Lauritzen; Hediye Erdjument-Bromage; Brittany Martin; Theresa C Swayne; Xuejun Jiang; Serge Przedborski
Journal:  J Neurosci       Date:  2019-07-12       Impact factor: 6.167

Review 6.  Skeletal muscle mitochondrial remodeling in exercise and diseases.

Authors:  Zhenji Gan; Tingting Fu; Daniel P Kelly; Rick B Vega
Journal:  Cell Res       Date:  2018-08-14       Impact factor: 25.617

Review 7.  Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes.

Authors:  Laura Scott; Valina L Dawson; Ted M Dawson
Journal:  Exp Neurol       Date:  2017-04-23       Impact factor: 5.330

Review 8.  Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases.

Authors:  Charleen T Chu
Journal:  Neurobiol Dis       Date:  2018-07-17       Impact factor: 5.996

9.  Evidence for Compartmentalized Axonal Mitochondrial Biogenesis: Mitochondrial DNA Replication Increases in Distal Axons As an Early Response to Parkinson's Disease-Relevant Stress.

Authors:  Victor S Van Laar; Beth Arnold; Evan H Howlett; Michael J Calderon; Claudette M St Croix; J Timothy Greenamyre; Laurie H Sanders; Sarah B Berman
Journal:  J Neurosci       Date:  2018-07-20       Impact factor: 6.167

Review 10.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.